搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
14 小时
on MSN
BridgeBio granted Perform rating at Oppenheimer on market challenges
BridgeBio Pharma BBIO) stock received a Perform rating from Oppenheimer on market challenges to its late-stage assets acoramidis and infigratinib. Read more here.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
US port strike ends
Helene's wake
Accused of sexual assault
Sentenced to 9 yrs in prison
Ex-Memphis cops guilty
To be closed indefinitely
California gang busted
TikTok star charged
Student loan plan ruling
Record heat bakes millions
US diagnostic errors study
Golf Hall of Famer dies
'Rust' gets premiere date
Fifth recall within a year
To hire 250,000 workers
Expands online recruitment
OH gov. declares emergency
Israel strikes central Beirut
US bans 2 Chinese firms
5 Chinese nationals charged
Fruit fly brain mapped
FDA: No longer in shortage
Mortgage rate ticks up
Dream fire coach Wright
Kirk becomes Category 4
Weekly jobless claims rise
CA deepfakes law blocked
Disrupt Russian hackers
Secures $4 billion credit line
Surveys Helene damage
反馈